Promotional effect of 27-hydroxycholesterol in the release of matrix metalloproteinases by lung fibroblasts

T. Kikuchi, H. Sugiura, T. Ichikawa, A. Koarai, M. Ichinose (Wakayama, Sendai, Japan)

Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Session: Stress responses and T-cell behaviour in the lung
Session type: Thematic Poster Session
Number: 3882
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Kikuchi, H. Sugiura, T. Ichikawa, A. Koarai, M. Ichinose (Wakayama, Sendai, Japan). Promotional effect of 27-hydroxycholesterol in the release of matrix metalloproteinases by lung fibroblasts. Eur Respir J 2013; 42: Suppl. 57, 3882

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Statins inhibit matrix metalloproteinase release from human lung fibroblasts
Source: Eur Respir J 2010; 35: 637-646
Year: 2010



Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 455s
Year: 2004

Composition of the cellular matrix, nutrition, and hypoxia modulate the secretion and activation of collagenases and their inhibitors in human lung cells
Source: Eur Respir J 2001; 18: Suppl. 33, 244s
Year: 2001

BIBF1120 inhibits fibroblasts proliferation and production of the extracellular matrix protein fibulin-1
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Effects of steroids and b-mimetics on matrix metalloproteinases expression in human lung primary cells
Source: Eur Respir J 2003; 22: Suppl. 45, 453s
Year: 2003

Surface-bound TIMP-1 on PMNs promotes pericellular proteolysis: A new culprit in COPD?
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015

Eosinophils contribute to extracellular matrix remodeling by enhancing pulmonary fibroblasts proliferation, differentiation and extracellular matrix proteins production in asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002

PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013


Cigarette smoke inhibits lung fibroblast proliferation by translational mechanisms
Source: Eur Respir J 2012; 39: 705-711
Year: 2012



The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway
Source: International Congress 2014 – ILDs 1
Year: 2014


Biological role of matrix metalloproteinases: a critical balance
Source: Eur Respir J 2011; 37: 191-208
Year: 2011



A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
Source: Eur Respir J 2011; 38: 1200-1214
Year: 2011



PP216 – Glucocorticoids exacerbate TGFß1 mediated fibrotic signalling in lung fibroblasts by inhibition of metalloproteinase expression and activity
Source: ERS Lung Science Conference 2021
Year: 2021

IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008

A potential role for extracellular matrix proteins in lung ageing in COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

Specific knockdown of versican 1 ameliorated the impairment of elastin deposit in pulmonary fibroblasts co-cultured with cigarette smoke
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013

Matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of metalloproteinase-1(TIMP-1) as non-invasive biomarkers of remodelling in asthma
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015


Production of matrix metalloprotease-9 (MMP-9) by alveolar macrophages (AMs) from smokers: effect of corticosteroids and phosphodiesterase inhibition
Source: Eur Respir J 2001; 18: Suppl. 33, 34s
Year: 2001